We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

39 hedge funds and large institutions have $151M invested in Global Cord Blood Corporation in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

10% more capital invested

Capital invested by funds: $138M → $151M (+$13.1M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

3% less funds holding

Funds holding: 4039 (-1)

Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
15
Reduced
6
Closed
6
Calls
Puts
Net Calls
Net Calls Change

CO Hedge Fund Activity: Q1 2019 in Review

39 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2019, worth a combined $151M — up 9.5% from $138M a quarter earlier.

Fund positioning in CO was balanced in Q1 2019: 6 funds opened new positions, 6 closed out, 15 added to existing stakes and 6 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.4M. The largest seller was Jayhawk Capital Management, cutting an estimated $3M.

  • 39 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2019, down from 40 in Q4 2018.
  • Funds reported $151M of Global Cord Blood Corporation stock for Q1 2019, up 9.5% quarter-over-quarter.
  • 6 funds opened new Global Cord Blood Corporation positions in Q1 2019 and 6 closed out, a net change of 0 holders.
  • The largest Global Cord Blood Corporation buyer in Q1 2019 was Renaissance Technologies, an estimated $1.4M added.
  • The largest Global Cord Blood Corporation seller in Q1 2019 was Jayhawk Capital Management, an estimated $3M sold.

Based on aggregated 13F filings for Q1 2019.